Pathway-Based Biomarker Search by High-Throughput Proteomics Profiling of Secretomes

被引:71
作者
Lawlor, Kevin [1 ]
Nazarlan, Arpi [1 ]
Lacomis, Lynne [1 ]
Tempst, Paul [1 ,2 ]
Villanueva, Josep [1 ,2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Prot Ctr, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA
关键词
secretome; LC-MS/MS; mass spectrometry; cancer biomarker; pathways analysis; BREAST-CANCER; TUMOR MICROENVIRONMENT; STATISTICAL-MODEL; CONDITIONED MEDIA; PLASMA PROTEOME; CELL-LINES; EXPRESSION; GROWTH; ACTIVATION; KINASE;
D O I
10.1021/pr8008572
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An efficient means for the identification of prognostic and predictive biomarkers is essential in today's cancer management. A new approach toward biomarker discovery has therefore been proposed, where pathways instead of individual proteins would be monitored and targeted. Recently, the 'secretome', a biological fluid that may be enriched with secreted and/or shed proteins from adjacent disease-relevant cancer cells, has been targeted for biomarker discovery. We describe a novel method for secretome analysis using "stacking gels", label-free relative quantitation, and pathway analysis. The protocol presented here increases the throughput of secretome analysis by approximately 1 order of magnitude compared to earlier methodologies. In the first application, six cancer cell lines from three different tissues were studied. The global secretome data sets obtained were analyzed using pathway analysis software to attempt integrating the experimental findings into a cellular signaling context. This suggested that several secretome proteins might be interconnected with intracellular canonical pathways. This, in turn, may eventually allow the use of secretomes for discovery of pathway-based biomarkers. When this strategy was applied to two breast cancer cell lines, it appeared that the IGF signaling and the plasminogen activating system may be differentially regulated in invasive breast cancer, but this remains speculative until it is verified in a clinical setting. In summary, the methodology proposed optimizes cell culture with sample fractionation and LC-MS to obtain the highest yield from cultured cell secretomes, with a focus on rational biomarker discovery through putative linkage with cancer relevant pathways.
引用
收藏
页码:1489 / 1503
页数:15
相关论文
共 66 条
[1]   Molecular characterization of the tumor microenvironment in breast cancer [J].
Allinen, M ;
Beroukhim, R ;
Cai, L ;
Brennan, C ;
Lahti-Domenici, J ;
Huang, HY ;
Porter, D ;
Hu, M ;
Chin, L ;
Richardson, A ;
Schnitt, S ;
Sellers, WR ;
Polyak, K .
CANCER CELL, 2004, 6 (01) :17-32
[2]   The human plasma proteome - History, character, and diagnostic prospects [J].
Anderson, NL ;
Anderson, NG .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (11) :845-867
[3]   Targeting tyrosine kinases in cancer: The second wave [J].
Baselga, Jose .
SCIENCE, 2006, 312 (5777) :1175-1178
[4]   Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis [J].
Beattie, J ;
Allan, GJ ;
Lochrie, JD ;
Flint, DJ .
BIOCHEMICAL JOURNAL, 2006, 395 :1-19
[5]   Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle [J].
Beaulieu, Lea M. ;
Whitley, Brand R. ;
Wiesner, I. Theodore F. ;
Rehault, Sophie M. ;
Palmieri, Diane ;
Elkahloun, Abdel G. ;
Church, Frank C. .
BIOESSAYS, 2007, 29 (10) :1029-1038
[6]   The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation [J].
Beavon, IRG .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (13) :1607-1620
[7]   Feature-based prediction of non-classical and leaderless protein secretion [J].
Bendtsen, JD ;
Jensen, LJ ;
Blom, N ;
von Heijne, G ;
Brunak, S .
PROTEIN ENGINEERING DESIGN & SELECTION, 2004, 17 (04) :349-356
[8]   Oncogenic pathway signatures in human cancers as a guide to targeted therapies [J].
Bild, AH ;
Yao, G ;
Chang, JT ;
Wang, QL ;
Potti, A ;
Chasse, D ;
Joshi, MB ;
Harpole, D ;
Lancaster, JM ;
Berchuck, A ;
Olson, JA ;
Marks, JR ;
Dressman, HK ;
West, M ;
Nevins, JR .
NATURE, 2006, 439 (7074) :353-357
[9]   The plasminogen activator inhibitor "paradox" in cancer [J].
Binder, Bernd R. ;
Mihaly, Judit .
IMMUNOLOGY LETTERS, 2008, 118 (02) :116-124
[10]  
Cheadle Chris, 2003, Appl Bioinformatics, V2, P209